Emiliano G Manueli Laos, Lily Zhang, Reed Berger, Francesco Bianco, Khaled Abdelhady, Francisco Schlottmann, Mario A Masrur
{"title":"套筒胃切除术后单吻合术十二指肠回肠旁路和Roux-en-Y胃旁路围术期安全性分析。","authors":"Emiliano G Manueli Laos, Lily Zhang, Reed Berger, Francesco Bianco, Khaled Abdelhady, Francisco Schlottmann, Mario A Masrur","doi":"10.1016/j.soard.2025.07.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although metabolic and bariatric surgery (MBS) is highly effective for weight management, revisional procedures are often needed after sleeve gastrectomy (SG). While Roux-en-Y gastric bypass (RYGB) has historically been the most commonly performed revisional procedure, single anastomosis duodeno-ileal bypass (SADI) is a more recently endorsed alternative.</p><p><strong>Objective: </strong>To compare the safety profile of revisional RYGB and SADI after SG in the first postoperative 30 days.</p><p><strong>Setting: </strong>United States of America.</p><p><strong>Methods: </strong>Using the 2022-2023 MBSAQIP database, patients undergoing revisional RYGB or SADI after SG were identified and matched using propensity scores. Demographic, medical, and perioperative variables were analyzed, including length of stay, operative time, complications, and 30-day readmission, reoperation, and mortality rates.</p><p><strong>Results: </strong>After propensity score matching, a total of 6108 patients were included; 4581 (75.0%) to RYGB group and 1527 (25.0%) to SADI group. Operative times were longer for RYGB (P = .03). Mean length of stay was 1.57 ± 1.84 days for RYGB and 1.44 ± 1.28 days for SADI (P < .01) Postoperative bowel obstruction was more common after RYGB (.9% vs .3%, P = .01). RYGB 30-day readmission rate was 5.5% and reoperation rate was 1.8%. SADI 30-day readmission rate was 4.3% and reoperation rate was 2.2% (P = .06 for readmission rates; P = .3 for reoperation rates). Thirty-day mortality was similarly low in both groups (Group 1: .2%, Group 2: .1%, P > .7).</p><p><strong>Conclusion: </strong>Revisional RYGB and SADI after SG are both safe and associated with low morbidity in a short-term period. However, SADI may offer advantages over RYGB for its lower risk of postoperative bowel obstruction.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Perioperative safety profile of single anastomosis duodeno-ileal bypass and Roux-en-Y gastric bypass after sleeve gastrectomy.\",\"authors\":\"Emiliano G Manueli Laos, Lily Zhang, Reed Berger, Francesco Bianco, Khaled Abdelhady, Francisco Schlottmann, Mario A Masrur\",\"doi\":\"10.1016/j.soard.2025.07.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although metabolic and bariatric surgery (MBS) is highly effective for weight management, revisional procedures are often needed after sleeve gastrectomy (SG). While Roux-en-Y gastric bypass (RYGB) has historically been the most commonly performed revisional procedure, single anastomosis duodeno-ileal bypass (SADI) is a more recently endorsed alternative.</p><p><strong>Objective: </strong>To compare the safety profile of revisional RYGB and SADI after SG in the first postoperative 30 days.</p><p><strong>Setting: </strong>United States of America.</p><p><strong>Methods: </strong>Using the 2022-2023 MBSAQIP database, patients undergoing revisional RYGB or SADI after SG were identified and matched using propensity scores. Demographic, medical, and perioperative variables were analyzed, including length of stay, operative time, complications, and 30-day readmission, reoperation, and mortality rates.</p><p><strong>Results: </strong>After propensity score matching, a total of 6108 patients were included; 4581 (75.0%) to RYGB group and 1527 (25.0%) to SADI group. Operative times were longer for RYGB (P = .03). Mean length of stay was 1.57 ± 1.84 days for RYGB and 1.44 ± 1.28 days for SADI (P < .01) Postoperative bowel obstruction was more common after RYGB (.9% vs .3%, P = .01). RYGB 30-day readmission rate was 5.5% and reoperation rate was 1.8%. SADI 30-day readmission rate was 4.3% and reoperation rate was 2.2% (P = .06 for readmission rates; P = .3 for reoperation rates). Thirty-day mortality was similarly low in both groups (Group 1: .2%, Group 2: .1%, P > .7).</p><p><strong>Conclusion: </strong>Revisional RYGB and SADI after SG are both safe and associated with low morbidity in a short-term period. However, SADI may offer advantages over RYGB for its lower risk of postoperative bowel obstruction.</p>\",\"PeriodicalId\":94216,\"journal\":{\"name\":\"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-08-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.soard.2025.07.019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.soard.2025.07.019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:虽然代谢和减肥手术(MBS)对体重管理非常有效,但在袖式胃切除术(SG)后经常需要翻修手术。Roux-en-Y胃旁路术(RYGB)历来是最常用的修复手术,单一吻合十二指肠回肠旁路术(SADI)是最近被认可的替代方法。目的:比较改良RYGB和SADI在SG术后30天内的安全性。背景:美利坚合众国。方法:使用2022-2023 MBSAQIP数据库,识别SG后进行修订RYGB或SADI的患者,并使用倾向评分进行匹配。分析了人口统计学、医学和围手术期变量,包括住院时间、手术时间、并发症、30天再入院、再手术和死亡率。结果:经倾向评分匹配后,共纳入6108例患者;RYGB组为4581 (75.0%),SADI组为1527(25.0%)。RYGB组手术时间更长(P = .03)。RYGB组平均住院时间为1.57±1.84天,SADI组平均住院时间为1.44±1.28天(P < 0.01)。9% vs。3%, p = 0.01)。RYGB 30天再入院率5.5%,再手术率1.8%。SADI 30天再入院率为4.3%,再手术率为2.2%(再入院率P = 0.06,再手术率P = 0.3)。两组的30天死亡率同样较低(第一组:。2%,第二组:。1%, p < 0.05)。结论:SG术后改版RYGB和SADI是安全的,且短期内发病率低。然而,与RYGB相比,SADI的优势在于其术后肠梗阻风险较低。
Perioperative safety profile of single anastomosis duodeno-ileal bypass and Roux-en-Y gastric bypass after sleeve gastrectomy.
Background: Although metabolic and bariatric surgery (MBS) is highly effective for weight management, revisional procedures are often needed after sleeve gastrectomy (SG). While Roux-en-Y gastric bypass (RYGB) has historically been the most commonly performed revisional procedure, single anastomosis duodeno-ileal bypass (SADI) is a more recently endorsed alternative.
Objective: To compare the safety profile of revisional RYGB and SADI after SG in the first postoperative 30 days.
Setting: United States of America.
Methods: Using the 2022-2023 MBSAQIP database, patients undergoing revisional RYGB or SADI after SG were identified and matched using propensity scores. Demographic, medical, and perioperative variables were analyzed, including length of stay, operative time, complications, and 30-day readmission, reoperation, and mortality rates.
Results: After propensity score matching, a total of 6108 patients were included; 4581 (75.0%) to RYGB group and 1527 (25.0%) to SADI group. Operative times were longer for RYGB (P = .03). Mean length of stay was 1.57 ± 1.84 days for RYGB and 1.44 ± 1.28 days for SADI (P < .01) Postoperative bowel obstruction was more common after RYGB (.9% vs .3%, P = .01). RYGB 30-day readmission rate was 5.5% and reoperation rate was 1.8%. SADI 30-day readmission rate was 4.3% and reoperation rate was 2.2% (P = .06 for readmission rates; P = .3 for reoperation rates). Thirty-day mortality was similarly low in both groups (Group 1: .2%, Group 2: .1%, P > .7).
Conclusion: Revisional RYGB and SADI after SG are both safe and associated with low morbidity in a short-term period. However, SADI may offer advantages over RYGB for its lower risk of postoperative bowel obstruction.